Hypermethylation of FBXL7 promoter correlates with downregulation of FBXL7 levels and advanced tumor grade in both pancreatic carcinoma and prostate cancer [24, 48]. The gene discussed is FBXL7; the disease is exocrine pancreatic carcinoma.